Please login to the form below
balugrastim
This page shows the latest balugrastim news and features for those working in and with pharma, biotech and healthcare.
EMA backs 15 new medicines for use in EU
tilmanocept) for the delineation and localisation of sentinel lymph nodes; and Teva's Egranli (balugrastim) to treat chemotherapy-induced neutropenia.
Latest news
-
Teva withdraws US filing for cancer biologic
Teva withdraws US filing for cancer biologic. FDA requests more data for balugrastim. ... Teva said this week it is "assessing its options" after withdrawing the US drug filing for long-acting white cell stimulator balugrastim.
-
Neulasta rival from Teva cleared in EU
Teva's biologics pipeline also includes reslizumab, a monoclonal antibody targeting interleukin-5 (IL-5) in phase III for moderate-to-severe asthma, and an albumin-fused G-CSF called balugrastim
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Account Director
-
Negotiable
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Account Director – Global Healthcare PR
-
Salary TBC
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Director Healthcare PR Communications
-
Salary TBC
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Scientific Team Lead
-
Competitive Salary
-
Associate Medical Director
-
Highly Competitive
- Experienced Editor, London, Medical Communications
-
Competitive package
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Account Director - Digital
-
Great salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Associate Medical Director
-
Salary TBC
- Account Manager, Healthcare Advertising
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
Subscribe to our email news alerts
- Cuttsy+Cuttsy launch their latest patient e-book
- McCann Health London launch Urban Eye Test
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Keytruda hits survival targets in first-line kidney cancer
- UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
- Let's throw it against the wall and see what sticks...
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
Quick links
Infographics
